Skip to main content
NCBI home page
British Journal of Industrial Medicine logoLink to British Journal of Industrial Medicine
. 1989 Apr;46(4):271–276. doi: 10.1136/oem.46.4.271

Inflammation generating potential of long and short fibre amosite asbestos samples.

K Donaldson 1, G M Brown 1, D M Brown 1, R E Bolton 1, J M Davis 1
PMCID: PMC1009766  PMID: 2540793

Abstract

Previous studies have shown that long thin asbestos fibres are more pathogenic in in vivo and more active in in vitro assays than short fibre samples. In the present study a long fibre amosite asbestos sample and a short fibre sample prepared from it were tested for ability to cause inflammation in the peritoneal cavity of the mouse; a UICC sample intermediate in fibre size and an inert compact dust, TiO2, were also tested. The ability of the dust samples to cause inflammation, as judged by macrophage and neutrophil recruitment, was ranked in the order long fibre greater than UICC greater than short fibre greater than TiO2. Ability of amosite samples to cause inflammation was therefore related to the proportion of long fibres. The enhanced ability of long fibres to cause inflammation and cause macrophage activation is probably a key factor in the ability of long fibres to cause pulmonary fibrosis and may also be important in fibre carcinogenesis.

Full text

PDF
271

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brown G. M., Cowie H., Davis J. M., Donaldson K. In vitro assays for detecting carcinogenic mineral fibres: a comparison of two assays and the role of fibre size. Carcinogenesis. 1986 Dec;7(12):1971–1974. doi: 10.1093/carcin/7.12.1971. [DOI] [PubMed] [Google Scholar]
  2. Bégin R., Rola-Pleszczynski M., Massé S., Nadeau D., Drapeau G. Assessment of progression of asbestosis in the sheep model by bronchoalveolar lavage and pulmonary function tests. Thorax. 1983 Jun;38(6):449–457. doi: 10.1136/thx.38.6.449. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Davis J. M., Addison J., Bolton R. E., Donaldson K., Jones A. D., Smith T. The pathogenicity of long versus short fibre samples of amosite asbestos administered to rats by inhalation and intraperitoneal injection. Br J Exp Pathol. 1986 Jun;67(3):415–430. [PMC free article] [PubMed] [Google Scholar]
  4. Davis J. M., Beckett S. T., Bolton R. E., Collings P., Middleton A. P. Mass and number of fibres in the pathogenesis of asbestos-related lung disease in rats. Br J Cancer. 1978 May;37(5):673–688. doi: 10.1038/bjc.1978.105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Davis J. M. The use of animal models for studies on asbestos bioeffects. Ann N Y Acad Sci. 1979;330:795–798. doi: 10.1111/j.1749-6632.1979.tb18785.x. [DOI] [PubMed] [Google Scholar]
  6. Donaldson K., Bolton R. E., Brown D., Douglas A. An improved macrophage spreading assay--a simple and effective measure of activation. Immunol Commun. 1984;13(3):229–244. doi: 10.3109/08820138409025464. [DOI] [PubMed] [Google Scholar]
  7. Gellert A. R., Langford J. A., Winter R. J., Uthayakumar S., Sinha G., Rudd R. M. Asbestosis: assessment by bronchoalveolar lavage and measurement of pulmonary epithelial permeability. Thorax. 1985 Jul;40(7):508–514. doi: 10.1136/thx.40.7.508. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Janoff A., White R., Carp H., Harel S., Dearing R., Lee D. Lung injury induced by leukocytic proteases. Am J Pathol. 1979 Oct;97(1):111–136. [PMC free article] [PubMed] [Google Scholar]
  9. Keogh B. A., Crystal R. G. Alveolitis: the key to the interstitial lung disorders. Thorax. 1982 Jan;37(1):1–10. doi: 10.1136/thx.37.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Lemaire I., Beaudoin H., Dubois C. Cytokine regulation of lung fibroblast proliferation. Pulmonary and systemic changes in asbestos-induced pulmonary fibrosis. Am Rev Respir Dis. 1986 Oct;134(4):653–658. doi: 10.1164/arrd.1986.134.4.653. [DOI] [PubMed] [Google Scholar]
  11. Martin B. M., Gimbrone M. A., Jr, Unanue E. R., Cotran R. S. Stimulation of nonlymphoid mesenchymal cell proliferation by a macrophage-derived growth factor. J Immunol. 1981 Apr;126(4):1510–1515. [PubMed] [Google Scholar]
  12. Martin T. R., Chi E. Y., Covert D. S., Hodson W. A., Kessler D. E., Moore W. E., Altman L. C., Butler J. Comparative effects of inhaled volcanic ash and quartz in rats. Am Rev Respir Dis. 1983 Jul;128(1):144–152. doi: 10.1164/arrd.1983.128.1.144. [DOI] [PubMed] [Google Scholar]
  13. Mossman B. T., Craighead J. E. Mechanisms of asbestos carcinogenesis. Environ Res. 1981 Aug;25(2):269–280. doi: 10.1016/0013-9351(81)90028-1. [DOI] [PubMed] [Google Scholar]
  14. Soter N. A., Wasserman S. I., Austen K. F. Cold urticaria: release into the circulation of histamine and eosinophil chemotactic factor of anaphylaxis during cold challenge. N Engl J Med. 1976 Mar 25;294(13):687–690. doi: 10.1056/NEJM197603252941302. [DOI] [PubMed] [Google Scholar]
  15. Sporn M. B., Roberts A. B. Peptide growth factors and inflammation, tissue repair, and cancer. J Clin Invest. 1986 Aug;78(2):329–332. doi: 10.1172/JCI112580. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Industrial Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES